Karlsen, T.L.S.; Mjelle, R.; Vagnildhaug, O.M.; Balstad, T.R.; Kristensen, A.K.; Slagsvold, J.E.; Westwik, G.S.; Elvebakken, H.; Hofsli, E.; Hatlevoll, I.;
et al. Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation. Curr. Oncol. 2025, 32, 620.
https://doi.org/10.3390/curroncol32110620
AMA Style
Karlsen TLS, Mjelle R, Vagnildhaug OM, Balstad TR, Kristensen AK, Slagsvold JE, Westwik GS, Elvebakken H, Hofsli E, Hatlevoll I,
et al. Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation. Current Oncology. 2025; 32(11):620.
https://doi.org/10.3390/curroncol32110620
Chicago/Turabian Style
Karlsen, Terese Louise Schmidberger, Robin Mjelle, Ola Magne Vagnildhaug, Trude Rakel Balstad, Are Korsnes Kristensen, Jens Erik Slagsvold, Ganna S. Westwik, Hege Elvebakken, Eva Hofsli, Ingunn Hatlevoll,
and et al. 2025. "Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation" Current Oncology 32, no. 11: 620.
https://doi.org/10.3390/curroncol32110620
APA Style
Karlsen, T. L. S., Mjelle, R., Vagnildhaug, O. M., Balstad, T. R., Kristensen, A. K., Slagsvold, J. E., Westwik, G. S., Elvebakken, H., Hofsli, E., Hatlevoll, I., & Solheim, T. S.
(2025). Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation. Current Oncology, 32(11), 620.
https://doi.org/10.3390/curroncol32110620
